IBDEI20C ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32039,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,32039,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,32039,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,32040,0)
 ;;=E89.0^^126^1643^10
 ;;^UTILITY(U,$J,358.3,32040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32040,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,32040,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,32040,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,32041,0)
 ;;=D35.2^^126^1643^12
 ;;^UTILITY(U,$J,358.3,32041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32041,1,3,0)
 ;;=3^Prolactinoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,32041,1,4,0)
 ;;=4^D35.2
 ;;^UTILITY(U,$J,358.3,32041,2)
 ;;=^5002145
 ;;^UTILITY(U,$J,358.3,32042,0)
 ;;=Z13.1^^126^1643^13
 ;;^UTILITY(U,$J,358.3,32042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32042,1,3,0)
 ;;=3^Screen,Diabetes
 ;;^UTILITY(U,$J,358.3,32042,1,4,0)
 ;;=4^Z13.1
 ;;^UTILITY(U,$J,358.3,32042,2)
 ;;=^5062700
 ;;^UTILITY(U,$J,358.3,32043,0)
 ;;=Z13.220^^126^1643^14
 ;;^UTILITY(U,$J,358.3,32043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32043,1,3,0)
 ;;=3^Screen,Lipids
 ;;^UTILITY(U,$J,358.3,32043,1,4,0)
 ;;=4^Z13.220
 ;;^UTILITY(U,$J,358.3,32043,2)
 ;;=^5062702
 ;;^UTILITY(U,$J,358.3,32044,0)
 ;;=Z13.29^^126^1643^15
 ;;^UTILITY(U,$J,358.3,32044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32044,1,3,0)
 ;;=3^Screen,Thyroid
 ;;^UTILITY(U,$J,358.3,32044,1,4,0)
 ;;=4^Z13.29
 ;;^UTILITY(U,$J,358.3,32044,2)
 ;;=^5062704
 ;;^UTILITY(U,$J,358.3,32045,0)
 ;;=R73.01^^126^1643^7
 ;;^UTILITY(U,$J,358.3,32045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32045,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,32045,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,32045,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,32046,0)
 ;;=R73.02^^126^1643^8
 ;;^UTILITY(U,$J,358.3,32046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32046,1,3,0)
 ;;=3^Impaired Glucose Tolerance
 ;;^UTILITY(U,$J,358.3,32046,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,32046,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,32047,0)
 ;;=R73.03^^126^1643^11
 ;;^UTILITY(U,$J,358.3,32047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32047,1,3,0)
 ;;=3^Prediabetes
 ;;^UTILITY(U,$J,358.3,32047,1,4,0)
 ;;=4^R73.03
 ;;^UTILITY(U,$J,358.3,32047,2)
 ;;=^8295662
 ;;^UTILITY(U,$J,358.3,32048,0)
 ;;=N70.01^^126^1644^15
 ;;^UTILITY(U,$J,358.3,32048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32048,1,3,0)
 ;;=3^Salpingitis,Acute
 ;;^UTILITY(U,$J,358.3,32048,1,4,0)
 ;;=4^N70.01
 ;;^UTILITY(U,$J,358.3,32048,2)
 ;;=^5015802
 ;;^UTILITY(U,$J,358.3,32049,0)
 ;;=A63.0^^126^1644^22
 ;;^UTILITY(U,$J,358.3,32049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32049,1,3,0)
 ;;=3^Verereal Warts
 ;;^UTILITY(U,$J,358.3,32049,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,32049,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,32050,0)
 ;;=B37.3^^126^1644^1
 ;;^UTILITY(U,$J,358.3,32050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32050,1,3,0)
 ;;=3^Candidiasis
 ;;^UTILITY(U,$J,358.3,32050,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,32050,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,32051,0)
 ;;=N72.^^126^1644^2
 ;;^UTILITY(U,$J,358.3,32051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32051,1,3,0)
 ;;=3^Cervicitis
 ;;^UTILITY(U,$J,358.3,32051,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,32051,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,32052,0)
 ;;=A74.89^^126^1644^3
